Thanks again for the update on the paper. The board/agora/shareholders really appreciated it. This brings us to the delay & i know its "in the hands of the CRO and Principal Investigators" but even so, there must be some kind of back & forth communications with r v x  given this long delay? Are you able to give shareholders any reason(s) for this slowness in recruiting? It's awfully hard to understand given the time that's past without dosing a single patient to date.  

 

Is it possible dosing has started & the company has not been made aware of this fact yet?

 

Anything of substance you could provide would again be much appreciated.

Regards,